Titan Pharmaceuticals Appoints Chay Weei Jye as CEO

Don't Miss our Black Friday Offers:

Titan Pharmaceuticals ( (TTNP) ) has issued an announcement.

Chay Weei Jye has been appointed as the new CEO, bringing extensive IT leadership experience from roles at Zchwantech, Affin Bank Berhad, and Malaysian Airlines. His strategic expertise in technology solutions and enterprise architecture is expected to drive the company’s growth, making this a significant development for investors watching the company’s trajectory.

Learn more about TTNP stock on TipRanks’ Stock Analysis page.

Trending Articles

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

More Related Articles

Info icon

This data feed is not available at this time.

Data is currently not available

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.